While these drugs are still under scrutiny, a new review of six studies of celicoxib (Celebrex) compared to a placebo in nearly 8,000 patients, which was published in the March 2008 issue of the journal Circulation, found that people with no established risk factors for heart disease, such as high cholesterol or high blood pressure, could safely take doses of up to 400 mg, twice a day, with no inc